Blood pressure response to angiotensin II in pregnant and lactating goats maintained on high or low sodium intake. 1987

K Olsson, and K Dahlborn, and B E Karlberg

Goats were kept on either high (274 mmol day-1) or low (68 mmol day-1) sodium intake during pregnancy, lactation, and anoestrus. High salt (HS) animals had about three times greater renal Na excretion than low salt (LS) animals, but the differences in plasma volume, protein concentration, and haematocrit were generally not significant. Angiotensin II (AII) was infused intravenously for 28-min periods in doses of 0.30, 0.75, or 1.00 nmol min-1. The increase in mean arterial blood pressure (MAP) during AII infusions was greater in HS than in LS goats, but became attenuated in all animals during the course of the pregnancy. In LS goats the MAP rise was smaller in late pregnancy than during lactation and anoestrus. In HS goats the rise in MAP was exaggerated in early pregnancy and was similar to lactation and anoestrus values in late pregnancy. During lactation and anoestrus the goats showed similar MAP increase in response to AII infusions. The pulse pressure was greater during AII infusions performed in early pregnancy, lactation and anoestrus than in late pregnancy. Cardiac arrhythmias were noted during AII infusions, most frequently during lactation and in HS goats in early pregnancy. The results show that a moderately elevated sodium intake causes a significantly higher MAP increase in response to AII infusions during pregnancy. This abolishes the reduction of the MAP increase to AII infusions during late pregnancy as compared to anoestrus; a phenomenon which is observed in goats on a low sodium intake.

UI MeSH Term Description Entries
D007774 Lactation The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN. Lactation, Prolonged,Milk Secretion,Lactations, Prolonged,Milk Secretions,Prolonged Lactation,Prolonged Lactations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011270 Pregnancy, Animal The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH. Animal Pregnancies,Animal Pregnancy,Pregnancies, Animal
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004039 Diet, Sodium-Restricted A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed) Diet, Low-Salt,Diet, Low-Sodium,Diet, Salt-Free,Diet, Low Salt,Diet, Low Sodium,Diet, Salt Free,Diet, Sodium Restricted,Diets, Low-Salt,Diets, Low-Sodium,Diets, Salt-Free,Diets, Sodium-Restricted,Low-Salt Diet,Low-Salt Diets,Low-Sodium Diet,Low-Sodium Diets,Salt-Free Diet,Salt-Free Diets,Sodium-Restricted Diet,Sodium-Restricted Diets
D005260 Female Females
D006041 Goats Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP. Capra,Capras,Goat
D000780 Anestrus A state of sexual inactivity in female animals exhibiting no ESTROUS CYCLE. Causes of anestrus include pregnancy, presence of offspring, season, stress, and pathology.
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000805 Angiotensin III A heptapeptide formed from ANGIOTENSIN II after the removal of an amino acid at the N-terminal by AMINOPEPTIDASE A. Angiotensin III has the same efficacy as ANGIOTENSIN II in promoting ALDOSTERONE secretion and modifying renal blood flow, but less vasopressor activity (about 40%). Des-Asp Angiotensin II,Des-Aspartyl-Angiotensin II,Angiotensin II, Des-Asp,Des Asp Angiotensin II,Des Aspartyl Angiotensin II

Related Publications

K Olsson, and K Dahlborn, and B E Karlberg
October 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Olsson, and K Dahlborn, and B E Karlberg
October 1996, Regulatory peptides,
K Olsson, and K Dahlborn, and B E Karlberg
October 2019, Brain research,
K Olsson, and K Dahlborn, and B E Karlberg
July 1964, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
K Olsson, and K Dahlborn, and B E Karlberg
February 1969, Endocrinology,
K Olsson, and K Dahlborn, and B E Karlberg
January 1975, Fukuoka igaku zasshi = Hukuoka acta medica,
K Olsson, and K Dahlborn, and B E Karlberg
April 1980, Endocrinologia japonica,
Copied contents to your clipboard!